155 related articles for article (PubMed ID: 32698394)
21. Histopathologic Diagnosis of Atypical Primary Vitreoretinal Lymphoma following Enucleation.
Sood AB; Yeh S; Mendoza P; Grossniklaus HE
Ocul Oncol Pathol; 2016 Oct; 2(4):242-245. PubMed ID: 27843904
[TBL] [Abstract][Full Text] [Related]
22. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
[TBL] [Abstract][Full Text] [Related]
23. DEVELOPMENT OF EPSTEIN-BARR VIRUS UVEITIS AFTER REMISSION OF PRIMARY VITREORETINAL LYMPHOMA.
Chahal BS; Rasmussen S; White VA; Forooghian F
Retin Cases Brief Rep; 2016; 10(2):131-3. PubMed ID: 26267526
[TBL] [Abstract][Full Text] [Related]
24. Primary vitreoretinal lymphoma: short review of the literature, results of a European survey and French guidelines of the LOC network for diagnosis, treatment and follow-up.
Malaise D; Houillier C; Touitou V; Choquet S; Maloum K; Le Garff-Tavernier M; Davi F; Vincent-Salomon A; Feuvret L; Hoang-Xuan K; Cassoux N; Soussain C;
Curr Opin Oncol; 2021 Sep; 33(5):420-431. PubMed ID: 34292201
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal immunoglobulin heavy chain gene rearrangement in Fuchs' uveitis.
Nakahara H; Kaburaki T; Tanaka R; Matsuda J; Takamoto M; Ohtomo K; Okinaga K; Komae K; Numaga J; Fujino Y; Aihara M
BMC Ophthalmol; 2018 Mar; 18(1):74. PubMed ID: 29523105
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate.
Zhao H; Wang X; Mao Y; Peng X
BMC Ophthalmol; 2020 Jan; 20(1):10. PubMed ID: 31906917
[TBL] [Abstract][Full Text] [Related]
27. Distinct Profiles of Soluble Cytokine Receptors Between B-Cell Vitreoretinal Lymphoma and Uveitis.
Takeda A; Yoshikawa H; Fukuhara T; Hikita S; Hijioka K; Otomo T; Arita R; Hisatomi T; Kimura K; Yoshida S; Kawano Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7516-23. PubMed ID: 26595610
[TBL] [Abstract][Full Text] [Related]
28. Clinical Features of Primary Vitreoretinal Lymphoma: A Single-center Study.
Kase S; Namba K; Iwata D; Mizuuchi K; Ito T; Hase K; Suzuki K; Onozawa M; Kitaichi N; Ishida S
Cancer Diagn Progn; 2021; 1(2):69-75. PubMed ID: 35403133
[TBL] [Abstract][Full Text] [Related]
29. Optical coherence tomography manifestations of primary vitreoretinal lymphoma.
Saito T; Ohguro N; Iwahashi C; Hashida N
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2319-2326. PubMed ID: 27251192
[TBL] [Abstract][Full Text] [Related]
30. Identification of Markers Predicting Clinical Course in Patients with IgG4-Related Ophthalmic Disease by Unbiased Clustering Analysis.
Tsubota K; Usui Y; Nemoto R; Goto H
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33348892
[TBL] [Abstract][Full Text] [Related]
31. How we diagnose and treat vitreoretinal lymphoma.
Fend F; Ferreri AJ; Coupland SE
Br J Haematol; 2016 Jun; 173(5):680-92. PubMed ID: 27133587
[TBL] [Abstract][Full Text] [Related]
32. Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma.
Yoshifuji K; Sadato D; Toya T; Motomura Y; Hirama C; Takase H; Yamamoto K; Harada Y; Mori T; Nagao T
Haematologica; 2024 Jun; ():. PubMed ID: 38841798
[TBL] [Abstract][Full Text] [Related]
33. Clinical Characteristics of Primary Vitreoretinal Lymphoma in an Indian Population.
Mahajan S; Nijhawan R; Rajwanshi A; Karkhur S; Mulkutar S; Dogra M; Lal V; Gupta V; Gupta A
Ocul Immunol Inflamm; 2017 Oct; 25(5):633-638. PubMed ID: 27003620
[TBL] [Abstract][Full Text] [Related]
34. High-Throughput MicroRNA Profiling of Vitreoretinal Lymphoma: Vitreous and Serum MicroRNA Profiles Distinct from Uveitis.
Minezaki T; Usui Y; Asakage M; Takanashi M; Shimizu H; Nezu N; Narimatsu A; Tsubota K; Umazume K; Yamakawa N; Kuroda M; Goto H
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545709
[TBL] [Abstract][Full Text] [Related]
35. [Malignant lymphomas of the eye].
Fend F; Süsskind D; Deuter C; Coupland SE
Pathologe; 2017 Nov; 38(6):515-520. PubMed ID: 28993856
[TBL] [Abstract][Full Text] [Related]
36. Primary vitreoretinal lymphoma.
Mulay K; Narula R; Honavar SG
Indian J Ophthalmol; 2015 Mar; 63(3):180-6. PubMed ID: 25971162
[TBL] [Abstract][Full Text] [Related]
37. Clinical Features of Primary and Systemic Metastatic Intraocular Lymphomas in Spanish Patients.
Llorenç V; Fuster C; Alba-Linero C; Moll-Udina A; Serrano A; Solé M; Sainz de la Maza M; Aldecoa I; Adán A
J Ophthalmol; 2019; 2019():6327041. PubMed ID: 31737358
[TBL] [Abstract][Full Text] [Related]
38. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
39. [Primary Intraocular Lymphoma: Relevance of Diagnostic Vitrectomy].
Le Guin CH; Metz K; Bornfeld N
Klin Monbl Augenheilkd; 2017 Dec; 234(12):1524-1532. PubMed ID: 29145691
[TBL] [Abstract][Full Text] [Related]
40. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
